S
Sabrina Rizzo
Researcher at University of Ferrara
Publications - 18
Citations - 202
Sabrina Rizzo is an academic researcher from University of Ferrara. The author has contributed to research in topics: Medicine & Immunology. The author has an hindex of 3, co-authored 9 publications receiving 33 citations.
Papers
More filters
Journal ArticleDOI
TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection.
Daria Bortolotti,Valentina Gentili,Sabrina Rizzo,Giovanna Schiuma,Silvia Beltrami,Giovanni Strazzabosco,M. Fernandez,Francesca Caccuri,Arnaldo Caruso,Roberta Rizzo +9 more
TL;DR: In this article, the authors investigated the role of pathogen-associated molecular patterns (PAMPs)-pattern recognition receptors (PRRs) interaction and showed that both TLR3 and TLR7 are involved in the control of innate immunity during lung SARS-CoV-2 infection.
Journal ArticleDOI
SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A Pathway.
TL;DR: It is shown for the first time that NK cells are affected by SP1 expression in lung epithelial cells via HLA-E/NKG2A interaction and the resulting NK cells’ exhaustion might contribute to immunopathogenesis in SARS-CoV-2 infection.
Journal ArticleDOI
Increased sHLA-G Is Associated with Improved COVID-19 Outcome and Reduced Neutrophil Adhesion.
Daria Bortolotti,Valentina Gentili,Sabrina Rizzo,Giovanna Schiuma,Silvia Beltrami,Savino Spadaro,Giovanni Strazzabosco,Gianluca Campo,Edgardo D. Carosella,Alberto Papi,Roberta Rizzo,Marco Contoli +11 more
TL;DR: In this article, the authors evaluated blood sHLA-E and HLA-G levels in hospitalized COVID-19 patients with respiratory failure and their relationship with clinical evolution, changes in endothelial activation biomarker profile, and neutrophil adhesion.
Journal ArticleDOI
Detailed In Vitro Pharmacological Characterization of the Clinically Viable Nociceptin/Orphanin FQ Peptide Receptor Antagonist BTRX-246040.
TL;DR: In all assays, BTRX-246040 behaves as a pure and selective antagonist at human recombinant and murine native NOP receptors displaying 3–10-fold higher potency than the standard antagonist SB-612111.
Journal ArticleDOI
Transparent Polymeric Formulations Effective against SARS-CoV-2 Infection.
Valentina Gentili,Daniele Pazzi,Sabrina Rizzo,Giovanna Schiuma,Edoardo Marchini,Stefania Papadia,Andrea Sartorel,Dario Di Luca,Francesca Caccuri,Carlo Alberto Bignozzi,Roberta Rizzo +10 more
TL;DR: In this article, two transparent polymeric compounds, containing silver and benzalkonium ions electrostatically bound to a polystyrene sulfonate backbone, were synthesized, through simple procedures, and evaluated for their antimicrobial properties against Gram-positive and Gram-negative bacteria and Candida albicans, and for their antiviral activity toward 229E and SARS-CoV-2 coronavirus.